BPI 2026 · CDMO & CRO

Aurigene Pharmaceutical Services at BPI 2026

Aurigene Pharmaceutical Services brings 1 presentation to BPI 2026 in Boston, and exhibits at Booth 944. Its session covers faster cell line and clone development for novel monospecific and multispecific antibodies heading to first-in-human studies. It presents an integrated discovery, development and manufacturing platform built on AuriCHO.

OrganizationBPI 2026 Attendance
1 Global Head of Discovery Services
aurigeneservices.com
CDMO & CROExhibitor
CRDMO offering integrated discovery, development and manufacturing services for small and large molecules, including antibodies, multispecifics and ADCs.
Booth
Exhibiting at Booth 944
Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm
Talk
Wed Sep 23
5:20pm–5:30pm
Accelerated Cell Line and Clone Development for Novel mono and multispecific Antibody FIH: An AuriCHO based Integrated CRDMO Platform
Innovation and Community Stage (Exhibit Hall)
Cell Line DevelopmentCMC & Manufacturing Strategy

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Aurigene Pharmaceutical Services

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction